| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |